Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study - Wikidata - awgldk - TriplyDB

Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study

Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study

http://www.wikidata.org/entity/Q33813279

about

Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study

http://www.wikidata.org/entity/Q33813279

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Medication-related issues asso ...... leukemia: a qualitative study

@ast

Medication-related issues asso ...... leukemia: a qualitative study

@en

type

label

Medication-related issues asso ...... leukemia: a qualitative study

@ast

Medication-related issues asso ...... leukemia: a qualitative study

@en

prefLabel

Medication-related issues asso ...... leukemia: a qualitative study

@ast

Medication-related issues asso ...... leukemia: a qualitative study

@en

P1433

Q33813279-E9205BF5-A89A-4FFF-B872-9F756498269F

P1476

Q33813279-C3759D9F-03D3-4B13-868B-18439016ED00

P2093

Q33813279-35939B71-ECE7-4F3A-8C75-AA2551BF7048

Q33813279-44803212-CDC7-42C1-BB4A-72335DB81AEB

Q33813279-9714B3D5-1BD4-4A8F-B11C-27E1B0C6844D

Q33813279-982DF99F-F45D-48EC-808C-392F091927BA

Q33813279-B1ED2C6B-66DC-4ADE-A3A9-BB1B67BC9ACC

Q33813279-C4F3DAF7-1388-40C6-8C00-6243D4257B62

Q33813279-F9DC31CE-03E7-49C1-A4C9-1BCBB6E1BC20

P2860

Q33813279-0445EC1A-DF7B-4F02-9062-491C84A7CE8B

Q33813279-08EC7D23-1F8D-4740-A9AF-FB99B7F31BDA

Q33813279-160A0840-8E49-4466-9995-A5769F423217

Q33813279-23A29C48-92CC-42CE-A6B3-235AE99EC405

Q33813279-2BFBF026-2EAD-4862-BD60-78D2853998BE

Q33813279-3B28AE48-EA3F-43EE-99A0-456AFD065F5A

Q33813279-3C5D1015-71D4-4396-8DDB-74BB1A264E9B

Q33813279-4A6ED0D5-761C-4E40-82C6-A0617AE1FB5B

Q33813279-4C57555E-E43F-4C0B-BFAC-6F4AB8C716FE

Q33813279-51B1F544-C1CE-417B-8603-301BFF0DF4E1

P304

Q33813279-0D0C5A63-BDAB-4597-BBF5-2935FE30ECAE

P31

Q33813279-B6B95776-4969-4E0F-A930-457FFA52BD0F

P356

Q33813279-0E9B6B3B-63A6-4884-82E2-AB2302BEDF73

P407

Q33813279-8862B8A6-B61C-41A3-86AE-20A4BB6B5004

P478

Q33813279-84E939FF-0DD6-46DA-B6BB-1A3B24211A17

P50

Q33813279-18DEF9A6-D2B6-4FE2-8001-E860526B2392

Q33813279-88D78014-8706-4A9B-AA8F-0B4AE1D798B3

P577

Q33813279-ADDF537A-E9D5-497D-BC61-C9A3E9C43B9C

P698

Q33813279-0593BBE7-0F4A-4EB8-AC28-7D1ED3C0DDA9

P921

Q33813279-457C203F-DF12-4849-A562-0508A940CA07

P932

Q33813279-5006D450-BABB-45E1-8507-BA0F3ED1CB2C

P356

P1433

Patient Preference and Adherence

P1476

Medication-related issues asso ...... leukemia: a qualitative study

@en

P2093

Bee Kim Tan

http://www.w3.org/2001/XMLSchema#string

Habiba Nazeera Begum Kamarul Jaman

http://www.w3.org/2001/XMLSchema#string

Ping Chong Bee

http://www.w3.org/2001/XMLSchema#string

Seng Beng Tan

http://www.w3.org/2001/XMLSchema#string

Sharmini Balashanker

http://www.w3.org/2001/XMLSchema#string

Siew Siang Chua

http://www.w3.org/2001/XMLSchema#string

Syed Carlo Edmund

http://www.w3.org/2001/XMLSchema#string

P2860

The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature.

Purposeful Sampling for Qualitative Data Collection and Analysis in Mixed Method Implementation Research.

Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey.

An update on imatinib mesylate therapy in chronic myeloid leukaemia patients in a teaching hospital in Malaysia.

Chronic Myelogenous Leukemia, Version 1.2014

Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient's perspective.

Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients.

Imatinib adherence associated clinical outcomes of chronic myeloid leukaemia treatment in Taiwan.

Measurement of adherence to BCR-ABL inhibitor therapy in chronic myeloid leukemia: current situation and future challenges.

The predictive value of early molecular response in chronic myeloid leukaemia patients treated with imatinib in a single real-world medical centre in a developing country.

P304

1027-1034

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/PPA.S132894

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Kian Meng Chang

P577

2017-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28652712

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

5476765

http://www.w3.org/2001/XMLSchema#string